Evidence‐based clinical practice guidelines for liver cirrhosis 2020
Hitoshi Yoshiji(Nara Medical University), Kazuhiko Koike(Kanto Central Hospital), Shuji Terai(Niigata University Medical and Dental Hospital), Hiroto Miwa(Toyo Institute of Food Technology), Kazuaki Chayama(RIKEN Center for Integrative Medical Sciences), Yoshinari Asaoka(The Japanese Society of Gastroenterological Surgery), Tooru Shimosegawa(Japan Pancreatic Disease Research Foundation), Yoichi Hiasa(Ehime University Hospital), Makiko Taniai(Tokyo Women's Medical University), Tetsuo Takehara(Osaka Gakuin University), Hiroki Nishikawa(Hyogo Medical University), Yoshiyuki Ueno(Yamagata Prefectural University of Health Sciences), Sumiko Nagoshi(Saitama Medical University), Takemi Akahane(The Japanese Society of Gastroenterological Surgery), Koji Ogawa(The Japanese Society of Gastroenterological Surgery), Isao Sakaida(Yamaguchi University), Masayuki Kurosaki(Musashino Red Cross Hospital), Takumi Kawaguchi(Kurume University), Masahito Shimizu(Gifu University Hospital), Nobuyuki Enomoto(The Japanese Society of Gastroenterological Surgery), Hisashi Hidaka(Kitasato University)
Cited by 202
Related Papers
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Consensus Proposals for a Unified System of Nomenclature of Hepatitis C Virus Genotypes *
|Hepatology|2005|1.5k
Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.
|Journal of Biological Chemistry|1990|1.5k
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k
KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.
|Journal of Biological Chemistry|1990|625